- Filed
- Nov 12, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Oct 31, 2021 | 4.75M sh |
| Cash And Equivalents | Q3 2021 · Sep 30, 2021 | $13.26K |
| Cash And Equivalents | Q3 2021 · Dec 31, 2020 | $20.26K |
| Cash And Equivalents | Q3 2021 · Sep 30, 2020 | $24.6K |
| Cash And Equivalents | Q3 2021 · Dec 31, 2019 | $30.13K |
| Current Liabilities | Q3 2021 · Sep 30, 2021 | $12.28M |
| Current Liabilities | Q3 2021 · Dec 31, 2020 | $13.07M |
| Total Liabilities | Q3 2021 · Sep 30, 2021 | $12.28M |
| Total Liabilities | Q3 2021 · Dec 31, 2020 | $13.11M |
| Current Assets | Q3 2021 · Sep 30, 2021 | $1.32M |
| Current Assets | Q3 2021 · Dec 31, 2020 | $1.39M |
| Total Assets | Q3 2021 · Sep 30, 2021 | $1.32M |
| Total Assets | Q3 2021 · Dec 31, 2020 | $1.39M |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 4.6M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 4.42M sh |
| Operating Cash Flow restated | Q3 2021 · Sep 30, 2020 | −$821.8K |
| Stockholders Equity | Q3 2021 · Sep 30, 2020 | −$11.69M |
| Stockholders Equity | Q3 2021 · Jun 30, 2020 | −$11.72M |
| Stockholders Equity | Q3 2021 · Dec 31, 2019 | −$11.29M |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | $0.01 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | −$0.09 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | $0.01 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | −$0.09 |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $203.26K |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $714.13K |
| Rd Expense | Q3 2021 · Sep 30, 2020 | $62.85K |
| Rd Expense | Q3 2021 · Sep 30, 2020 | $187.24K |
| Net Income | Q3 2021 · Sep 30, 2020 | $31.86K |
| Net Income | Q3 2021 · Sep 30, 2020 | −$401.6K |
| Net Income | Q3 2021 · Jun 30, 2020 | −$433.46K |
| Operating Income | Q3 2021 · Sep 30, 2020 | −$203.26K |
| Operating Income | Q3 2021 · Sep 30, 2020 | −$714.13K |